| | LOC121466733, LOC121468000 +2048 more | Copy number loss | See cases | |
| | LOC130010147, LOC130010148 +2049 more | Copy number gain | See cases | |
| | LOC130009360, LOC130009361 +2047 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC130009909, LOC130009910 +2044 more | Copy number gain | See cases | |
| | LINC00333, LINC00343 +2045 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LOC112163664, LOC112163665 +2040 more | Copy number gain | See cases | |
| | LOC121838573, LOC121838574 +2028 more | Copy number gain | See cases | |
| | LOC130009528, LOC130009529 +620 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LINC00462, LINC00463 +2021 more | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number loss | See cases | |
| | | Copy number gain | See cases | |
| | | Copy number gain | See cases | |
| | LINC00434, LINC00437 +735 more | Copy number gain | See cases | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | BRCA2, LOC106721785 +1 more | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | LOC106721785, ZAR1L +1 more | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +2 more | Deletion | Breast-ovarian cancer, familial, susceptibility to, 2 +1 more | |
| | | Single nucleotide variant | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant | Hereditary breast ovarian cancer syndrome +3 more | |
| | | Duplication | not provided | |
| | | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +3 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | BRCA2, LOC106721785 +1 more | Deletion | Hereditary breast ovarian cancer syndrome | |
| | LOC106721785, LOC112163653 +3 more | Deletion | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant | not provided +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant | Fanconi anemia complementation group D1 +1 more | |
| | | Single nucleotide variant | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Duplication | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Familial cancer of breast | |
| | | Insertion (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Deletion (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Insertion (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | not provided +1 more | |
| | | Deletion (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Indel (5 prime UTR variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Deletion (5 prime UTR variant) | not specified | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | BRCA2-related disorder +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Deletion (5 prime UTR variant) | not specified +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Deletion (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | not specified +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (5 prime UTR variant) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (splice donor variant) | Hereditary breast ovarian cancer syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Microsatellite (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Microsatellite (intron variant) | Hereditary breast ovarian cancer syndrome | |
| | | Single nucleotide variant (intron variant) | not provided +1 more | |